TipRanks
Go Ultimate55% OFF

China Medicine (CHME) Financial Statements

China Medicine Financial Overview

China Medicine's market cap is currently $502.18K. The company's EPS TTM is $0.08; its P/E ratio is -145.86; China Medicine has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Q3 10Q2 10Q1 10
Income Statement
Total Revenue$ 17.55M$ 17.19M$ 10.57M
Gross Profit$ 5.80M$ 6.11M$ 3.25M
Operating Income$ 2.49M$ 3.79M$ 1.25M
EBITDA$ 2.91M$ 4.26M$ 1.71M
Net Income$ 2.22M$ 4.10M$ 1.80M
Balance Sheet
Cash & Short-Term Investments$ 7.85M$ 9.00M$ 11.09M
Total Assets$ 134.04M$ 135.14M$ 138.54M
Total Debt$ 3.20M$ 4.87M$ 11.41M
Net Debt$ -4.65M$ -4.13M$ 326.46K
Total Liabilities$ 56.12M$ 61.85M$ 77.65M
Stockholders' Equity$ 77.63M$ 72.93M$ 60.45M
Cash Flow
Free Cash Flow$ -4.78M$ -3.61M$ 1.36M
Operating Cash Flow$ -346.56K$ -3.51M$ 1.43M
Investing Cash Flow$ -3.71M$ -38.91K$ -77.03K
Financing Cash Flow$ 2.81M$ 1.42M$ 9.26M

Currency in USD